2B or Not 2B? That Was the Question for Aspartame In our recent Carrier Management article, titled “2B or Not 2B? That Was the Question for Aspartame,” we delve into…
read moreFilter posts by:
Aon panel debate: Casualty capacity still available as renewal dynamics shift | The Insurer TV Praedicat CEO Robert Reville had the pleasure of joining Aon’s panel debate on The…
read moreOur own David Loughran and Graham Tibbets join Matthew B. Anderson, Travis Grulkowski and Drew Goth to co-author the newest report from Milliman, The “forever chemical” risk is now: An…
read moreKBW released a report on the webinar they held recently with our own Robert Reville and Adam Grossman. It featured a great discussion on the challenges PFAS poses to casualty…
read morePraedicat’s Reville: PFAS tops list of industry casualty risks | The Insurer TV Join us for an insightful and in-depth conversation between George Abbott, the host of The Insurer TV,…
read moreSeptember 14, 2023 – Praedicat President and CEO Robert Reville discusses the conversations he’s having in Monte Carlo around the growth of casualty, the challenges insurers and reinsurers are facing,…
read moreMonte Carlo 2023 Coverage September 11, 2023: In the face of rising litigation, how is the industry managing liability exposure to per- and polyfluoroalkyl substances (PFAS)? That is the question…
read moreAugust 30, 2023: D&O Underwriters May Be Worried About the Wrong Greenhouse Gas Greenwashing lawsuits with respect to climate change, while still relatively uncommon, have seen an uptick in recent…
read moreClimate casualty risk Increasingly, climate advocates are turning to the courts to seek accountability and redress, and that means new climate-related emerging risks for casualty insurers. It soon may be…
read moreJuly 2023 – The PFAS investment opportunity PFAS may very well be the next asbestos. But PFAS may also be the next big investment opportunity. If you are skeptical, we…
read moreJune 8, 2023: Endocrine Disruption Litigation Has Arrived In their latest article for Carrier Management, Praedicat’s David Loughran and Adam Grossman explore the emergence of endocrine disruption as a major…
read moreMarch 9th, 2022: Casualty Underwriting: The Original ESG In their latest article with Carrier Management, David Loughran and Robert Reville examine a topic that is top of mind for investors,…
read more